Oral Physostigmine as Treatment for Primary Degenerative Dementia: A Double-Blind Placebo-Controlled Inpatient Trial

Michael A. Jenike, Marilyn Albert, Lee Baer, Jeanette Gunther

Research output: Contribution to journalArticle

Fingerprint Dive into the research topics of 'Oral Physostigmine as Treatment for Primary Degenerative Dementia: A Double-Blind Placebo-Controlled Inpatient Trial'. Together they form a unique fingerprint.

Medicine & Life Sciences